Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania

ABSTRACT

The involvement of the multi-drug-resistant 1 P-glycoprotein gene (MDR1 P-gp) in the transport of antidepressants across the blood–brain barrier makes it a good candidate for the prediction of antidepressant response and side effects. We investigated the role of the MDR1 P-gp gene in predicting the induction of mania in bipolar patients (BP) treated with proserotonergic drugs. Participants met the DSM-IV criteria for BP or BPII and had at least one depressive episode treated with proserotonergic antidepressants. The first group (n=26) included patients with at least one DSM-IV manic/hypomanic episode developed during antidepressant treatment; the second group (N=29) included patients with no antidepressant-induced switches. The common polymorphism of the MDR1 was genotyped for both groups and comparison was made with respect to the presence/absence of induced mania between the two groups. No association between antidepressant-induced mania and the MDR1 alleles or genotypes was found (χ2=1.85, 2 df, P=0.39; χ2=0.13, 1 df, P=0.72).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM . Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1998; 39: 361–398.

    Article  Google Scholar 

  2. Uhr M, Steckler T, Yassouridis A, Holsboer F . Penetration of amitriptyline, but not of aluoxetine, into brain is enhanced in mice with blood–brain barrier deficiency due to mdr1a P-glycoprotein gene disruption. Neuropsychopharmacology 2000; 22: 380–387.

    Article  CAS  Google Scholar 

  3. McGuffin P, Katz R . The genetics of depression and manic-depressive disorder. Br J Psychiatry 1989; 155: 294–304.

    Article  CAS  Google Scholar 

  4. Gershon ES . Genetics. In: Goodwin FK, Jamison KR (eds). Manic-Depressive Illness. Oxford University Press: New York, NY 1990; pp 373–401.

    Google Scholar 

  5. Nurnberger Jr JI, Gershon ES . Genetics. In: Paykel ES (ed). Handbook of Affective Disorders. Churchill Livingstone Inc.: New York, NY 1992; pp 131–148.

    Google Scholar 

  6. Hoffmeyer S, Burk O, Richter OV, Arnold HP, Brockmoller J, Johne A et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473–3478.

    Article  CAS  Google Scholar 

  7. Verstuyft C, Schwab M, Schaeffeler E, Kerb R, Brinkmann U, Jaillon P et al. Digoxin pharmacokinetics and MDR1 genetic polymorphisms. Eur J Clin Pharmacol 2003; 58: 809–812.

    Article  CAS  Google Scholar 

  8. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwartz UI et al. Identification of functionally variant MDR1 alleles among European Americans and Americans. Clin Pharmacol Ther 2001; 70: 189–199.

    Article  CAS  Google Scholar 

  9. Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U et al. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 2002; 53: 526–534.

    Article  CAS  Google Scholar 

  10. Hitzl M, Drescher S, van der Kuip H, Schaffeler E, Fischer J, Schwab M et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56(+) natural killer cells. Pharmacogenetics 2001; 11: 293–298.

    Article  CAS  Google Scholar 

  11. Morita Y, Sakaeda T, Horinouchi M, Nakamura T, Kuroda K, Miki I et al. MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects. Pharm Res 2003; 20: 552–556.

    Article  CAS  Google Scholar 

  12. Roberts R, Joyce P, Mulder R, Begg E, Kennedy MA . A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated with major depression. Pharmacogenomics J 2002; 2: 191–196.

    Article  CAS  Google Scholar 

  13. Wehr TA, Goodwin FK . Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144: 1403–1411.

    Article  CAS  Google Scholar 

  14. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L . Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130–1138.

    Article  CAS  Google Scholar 

  15. Howland RH . Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol 1996; 16: 425–427.

    Article  CAS  Google Scholar 

  16. Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL . Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 1998; 59: 374–379.

    Article  CAS  Google Scholar 

  17. Angst J . Switch from depression to mania: a record survey over decades between 1920 and 1982. Psychopathology 1985; 18: 140–154.

    Article  CAS  Google Scholar 

  18. Mundo E, Walker M, Cate T, Macciardi F, Kennedy JL . The role of serotonin transporter gene in antidepressant-induced mania in bipolars. Arch Gen Psychiatry 2000; 47(Suppl): 135S.

    Google Scholar 

  19. Lahiri DK, Nurnberger JI . A rapid no-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis. Nucleic Acids Res 1991; 19: 5444.

    Article  CAS  Google Scholar 

  20. Tang K, Ngoi S, Gwee P, Chua JMZ, Lee EJD, Chong SS et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics 2002; 12: 437–450.

    Article  CAS  Google Scholar 

  21. Coryell W, Endicott J, Keller M . Rapid cycling affective disorder: demographics, diagnosis, family history and course. Arch Gen Psychiatry 1992; 49: 126–131.

    Article  CAS  Google Scholar 

  22. Mahar Doan KM, Humphreys JE, Webster LO, Wring SA, Shampine LJ, Serabjit-Singh CJ et al. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J Pharmacol Exp Therap 2002; 303: 1029–1037.

    Article  Google Scholar 

  23. Uhr M, Grauer MT, Holsboer F . Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry, Print copy in press (original) published online May 3, 2003, at http://www-east.elsevier.com/bps/prepub.htm).

  24. Uhr M, Grauer MT . abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice. J Psychiatr Res 2003; 37: 179–185.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J L Kennedy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Luca, V., Mundo, E., Trakalo, J. et al. Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania. Pharmacogenomics J 3, 297–299 (2003). https://doi.org/10.1038/sj.tpj.6500196

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500196

Keywords

This article is cited by

Search

Quick links